产品: KCNA1 抗体
货号: AF7543
描述: Rabbit polyclonal antibody to KCNA1
应用: WB
文献验证:
反应: Human, Rat
预测: Xenopus
蛋白号: Q09470
RRID: AB_2843907

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Rat
克隆:
Polyclonal
特异性:
KCNA1 Antibody detects endogenous levels of total KCNA1.
RRID:
AB_2843907
引用格式: Affinity Biosciences Cat# AF7543, RRID:AB_2843907.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

AEMK; EA1; Episodic ataxia with myokymia; HBK1; HUK1; Kca1 1; Kcna1; KCNA1_HUMAN; Kcpvd; KV1.1; MBK1; mceph; MGC124402; MGC126782; MGC138385; MK1; MK1, mouse, homolog of KV1.1; Potassium channel protein 1; Potassium voltage gated channel shaker related subfamily member 1; Potassium voltage gated channel subfamily A member 1; Potassium voltage gated channel, shaker related subfamily, member 1 (episodic ataxia with myokymia); Potassium voltage-gated channel subfamily A member 1; RBK1; RCK1; Shak; Shaker related subfamily member 1; Voltage gated potassium channel subunit Kv1.1; Voltage-gated K(+) channel HuKI; Voltage-gated potassium channel HBK1; Voltage-gated potassium channel subunit Kv1.1;

抗原和靶标

免疫原:

A synthesized peptide derived from human KCNA1, corresponding to a region within C-terminal amino acids.

基因/基因ID:

文献引用

1). Pulp inflammation induces Kv1.1 K+ channel down‐regulation in rat thalamus. ORAL DISEASES, 2022 (PubMed: 33811796) [IF=2.9]

Application: IHC    Species: Rat    Sample: gingival tissue

FIGURE 3 Immunohistochemical localization of Kv1.1 and GFAP in the contralateral thalamus after the application of MO. (a-f) Kv1.1- expressing axons and (h-m) GFAP-expressing astrocytes in the normal+saline group (a, h), normal+LA group (d, k), MO+saline group (b, c, i, j), and MO+LA group (e, f, l, m) 1 hr (b, e, i, l) and 24 hr (c, f, j, m) after the application of MO. Arrows indicate Kv1.1-expressing areas. Scale bars: 40 µm. (g) The density of the Kv1.1-expressing area and (n) number of GFAP-expressing astrocytes in the contralateral thalamus 0 (no pulp treatment), 1, and 24 hr after the application of MO. *p < .05 (n = 6 each, the Kruskal–Wallis test with Dunn's multiple comparison test). Groups with the same letters were not significantly different from each other.

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.